Pharmacology of estrogens
Author:
Shellenberger T. E.
Publisher
Springer Netherlands
Reference53 articles.
1. Lyrenàs, S., Carlstrôm, K., Bàckstrôm, T. and von Schoultz, B. (1981). A comparison of serum oestrogen levels after percutaneous and oral administration of oestrodiol-17 j8. Br. J. Obstet. Gynaecol, 88, 181–7 2. Helgason, S., Damber, M.-G., von Schoultz, B. and Stigbrand, T. (1981). Estrogenic potency of oral replacement therapy estimated by the induction of pregnancy zone protein. Acta Obstet. Gynecol. Scand, 60, 75–9 3. Helgason, S. (1982). Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects. Acta Obstet. Gynecol. Scand, Suppl. 107 4. Elkik, F., Gompel, A., Mercier-Bodard, C., Kutten, F., Guyenne, P. N., Corvol, P. and Mauvais-Jarvis, P. (1982). Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in post-menopausal women. Am. J. Obstet. Gynecol, 143, 888–92 5. Fâhraeus, L. and Wallentin, L. (1983). High density lipoprotein subfractions during oral and cutaneous administration of 1713-estradiol to menopausal women. J. Clin. Endocrinol. Metab, 56, 797–801
|
|